CVS · CVS HEALTH Corp

$97.16 +2.17 (+2.28%) At close · Aug 14

Market Cap

$124.26B

1.28B

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized

$20,000,000,000

as of 2022-11-17 · total across 2 concurrent programs

Remaining Authorization

$10,000,000,000

as of 2026-06-30

Program Utilization

50.0% $10,000,000,000 used of $20,000,000,000

Concurrent Repurchase Programs

Authorized	As of	Remaining	Remaining as of	Source
$10,000,000,000	2022-11-17	$10,000,000,000	2026-06-30	10-Q, filed 2026-08-05
$10,000,000,000	2021-12-09	$1,500,000,000	2026-06-30	10-Q, filed 2026-08-05

Cash spent on buybacks by quarter

Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Fiscal Year Ended	Cash Spent	Shares	Avg Price	Source
2025-12-31	$0	—	—	10-K, filed 2026-02-10
2024-12-31	$3,023,000,000	—	—	10-K, filed 2026-02-10
2023-12-31	$2,012,000,000	—	—	10-K, filed 2026-02-10
2022-12-31	$3,500,000,000	—	—	10-K, filed 2025-02-12
2021-12-31	$0	0	—	10-K, filed 2024-02-07
2020-12-31	$0	0	—	8-K, filed 2023-05-25
2019-12-31	$0	—	—	10-K, filed 2020-02-18
2018-12-31	$0	—	—	10-K, filed 2020-02-18
2017-12-31	$4,361,000,000	55,400,000	$78.72	10-K, filed 2020-02-18
2016-12-31	$4,461,000,000	47,500,000	$93.92	8-K, filed 2019-08-08
2015-12-31	$5,001,000,000	—	—	10-K, filed 2018-02-14
2014-12-31	$4,001,000,000	—	—	10-K, filed 2017-02-09
2013-12-31	$3,976,000,000	—	—	10-K, filed 2016-02-09
2012-12-31	$4,330,000,000	—	—	10-K, filed 2015-02-10
2011-12-31	$3,001,000,000	—	—	10-K, filed 2014-02-11
2010-12-31	$1,500,000,000	—	—	10-K, filed 2013-02-15
2009-12-31	$2,477,000,000	—	—	10-K, filed 2012-02-17
2008-12-31	$23,000,000	—	—	10-K, filed 2011-02-18
2007-12-29	$5,370,000,000	—	—	10-K, filed 2010-02-26

Quarter Ended	Cash Spent	Shares	Avg Price	Source
2025-12-31	$0 Δ	—	—	10-K, filed 2026-02-10
2025-09-30	$0 Δ	—	—	10-Q, filed 2025-10-29
2025-06-30	$0 Δ	—	—	10-Q, filed 2025-07-31
2025-03-31	$0	—	—	10-Q, filed 2025-05-01
2024-12-31	$0 Δ	—	—	10-K, filed 2026-02-10
2024-03-31	$3,027,000,000	—	—	10-Q, filed 2025-05-01
2023-03-31	$2,018,000,000	—	—	10-Q, filed 2024-05-01
2022-12-31	$1,500,000,000 Δ	—	—	10-K, filed 2025-02-12
2022-09-30	$0 Δ	—	—	10-Q, filed 2023-11-01
2022-06-30	$0 Δ	—	—	10-Q, filed 2023-08-02
2022-03-31	$2,000,000,000	—	—	10-Q, filed 2023-05-03
2021-12-31	$0 Δ	—	—	10-K, filed 2024-02-07

Key facts CIK 64803 CUSIP 126650100 13F (30d) 1803 filings 1737 filers Visit website Investor relations